Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.100
+0.197 (21.82%)
At close: Jul 3, 2025, 1:00 PM
1.090
-0.010 (-0.91%)
After-hours: Jul 3, 2025, 4:59 PM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $5.65 million as of July 3, 2025. Its market cap has increased by 53.70% in one year.
Market Cap
5.65M
Enterprise Value
1.03M
1-Year Change
53.70%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.17M to $5.65M, a decrease of -78.42%. That is a compound annual growth rate of -32.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 4.64M | -23.35% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.13% |
| Dec 30, 2022 | 7.82M | -59.16% |
| Dec 27, 2021 | 19.14M | -26.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 306.47B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |